萨默斯价值基金在2025年12月2日购买了Inspire医疗系统的股份,该医疗系统是睡眠敏化装置的制造者。 The Summers Value Fund bought shares in Inspire Medical Systems, a sleep apnea device maker, in Q2 2025.

根据证交会的档案资料,夏季价值基金在2025年第二季度的投资组合中增加了Inspire医疗系统(INSP)。 The Summers Value Fund added Inspire Medical Systems (INSP) to its portfolio in the second quarter of 2025, according to SEC filings. 这项投资标志着医疗技术部门的新地位,重点是可植入的设备,用于治疗妨碍睡眠的睡眠性呼吸道。 The investment marks a new position in the medical technology sector, focusing on implantable devices for treating obstructive sleep apnea. 这一行动反映了基金对公司增长前景和技术优势的信心,符合基金针对价值低估、基本面强的公司的战略。 The move reflects the fund’s confidence in the company’s growth prospects and technological edge, aligning with its strategy of targeting undervalued firms with strong fundamentals. 虽然没有披露确切的投资规模和获得的股份,但这一增加表明,在对最低侵入性解决方案的需求不断增长的情况下,机构对创新的睡眠性脑膜病治疗越来越感兴趣。 While the exact investment size and shares acquired were not disclosed, the addition signals growing institutional interest in innovative sleep apnea treatments amid rising demand for minimally invasive solutions.